MedTrace Logo

Analgesic Effect of Serratus Plane Block With Adjuvant Agents in Breast Cancer Surgery

NCT07081581 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 75

Last updated 2025-07-23

No results posted yet for this study

Summary

Pain after breast surgery has been described as moderate to severe in intensity and, if inadequately treated, increases postoperative morbidity, hospital cost, and the incidence of persistent postoperative pain. Serratus anterior plane block is an interfascial injection technique for analgesia of the chest wall. The aim of this study was to investigate the effect of magnesium and dexmedetomidine as adjuvant agents on postoperative analgesia in serratus anterior plane block in patients undergoing modified radical mastectomy.

Conditions

Interventions

DRUG

Bupivacain

In Group B( control group), bupivacaine was given as additional medication in the serratus block application.

DRUG

Bupivacaine and Magnesium sulfate

In Group M, bupivacaine and magnesium were given as additional medication in the serratus block application.

DRUG

Bupivacaine and Dexmedetomidine ile Blokaj

In Group D, bupivacaine and dexmedetomidine were given as additional medication in the serratus block application.

Sponsors & Collaborators

  • Sultan Abdulhamid Han Training and Research Hospital, Istanbul, Turkey

    lead OTHER

Principal Investigators

  • Dilek MD Metin Yamac · Sultan Abdülhamid Han education and research hospital

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
30 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-08-01
Primary Completion
2023-02-01
Completion
2023-03-01

Countries

  • Turkey (Türkiye)

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07081581 on ClinicalTrials.gov